Screener
Eli Lilly LLY Other, net
Other, net at other companies
Other financials
Where this comes from
Reported directly by Eli Lilly in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.
The source filing: Eli Lilly’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 2:40 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000059478-26-000081
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Proceeds from issuance of long-term debt | 8,941 | 6,461 |
| Repayments of long-term debt | (1,623) | (778) |
| Purchases of common stock | (3,957) | (1,892) |
| Other financing activities, net | (595) | (717) |
| Net Cash Provided by Financing Activities | 4,956 | 135 |
| Effect of exchange rate changes on cash and cash equivalents | 15 | 407 |
| Net increase in cash and cash equivalents | 1,682 | 108 |
| Cash and cash equivalents at January 1 | 7,268 | 3,268 |
Item 1. Financial Statements
FAQ
- What is Eli Lilly's other, net?
- Eli Lilly (LLY) reported other, net of -$4M in Q2 2026.
- How has Eli Lilly's other, net changed year-over-year?
- Eli Lilly's other, net increased by 87.1% year-over-year, from -$31M to -$4M.
- What is the long-term trend for Eli Lilly's other, net?
- Over 4 years (2021 to 2025), Eli Lilly's other, net has grown at a 27.1% compound annual growth rate (CAGR), from -$295.9M to -$772M.
- What does other, net mean?
- Includes miscellaneous cash flows related to financing activities that are not categorized as debt issuance, dividends, or share repurchases. This may include changes in non-controlling interests, debt issuance costs, or other unique financing-related transactions. It provides a comprehensive view of non-standard financing cash movements.
Ask your AI about Eli Lilly's other, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude